Fisetin and Brain aging

6535 Views
Was this article interesting to you?

Scientific Sources

What is fisetin and where does it come from?

Fisetin is a flavonoid antioxidant found in strawberries, apples, persimmons, grapes, onions, and cucumbers. Despite being present in foods, dietary intake provides very low amounts (typically under 1mg daily). Fisetin has gained attention for its neuroprotective, anti-inflammatory, and senolytic (removing senescent cells) properties, with research suggesting significant benefits for brain aging and overall longevity.

How does fisetin protect the brain and prevent neurological disorders?

Fisetin protects brain health through multiple mechanisms including powerful antioxidant activity reducing oxidative stress, anti-inflammatory effects reducing neuroinflammation, promoting neurotrophic factors supporting neuron survival and growth, protecting mitochondrial function in brain cells, and reducing accumulation of toxic proteins (amyloid, tau). Research shows fisetin may help prevent or slow Alzheimer's disease, Parkinson's disease, stroke damage, and age-related cognitive decline.

What is the bioavailability problem with fisetin and how is it solved?

Standard fisetin has poor bioavailability - most is poorly absorbed and rapidly eliminated. Pharmacokinetic studies show formulated fisetin using advanced delivery systems achieves comparable blood levels with just 200mg compared to 1000mg of standard fisetin (5-fold improvement). Enhanced formulations use technologies like liposomal encapsulation or specialized complexing to dramatically improve absorption and bioavailability.

What are fisetin's senolytic properties and why do they matter?

Senolytic compounds selectively eliminate senescent cells - damaged cells that accumulate with age and secrete inflammatory factors (SASP - senescence-associated secretory phenotype) that accelerate aging. Fisetin is one of the most potent natural senolytics identified. By clearing senescent cells, fisetin may reduce inflammation, improve tissue function, and extend healthspan. This senolytic activity complements its neuroprotective effects.

What is the recommended fisetin dosage?

Research uses various protocols. For neuroprotection, 100-200mg daily of enhanced bioavailability fisetin is typical. For senolytic effects, some protocols use higher intermittent dosing (e.g., 1000mg daily for 2 consecutive days per month), though enhanced formulations may achieve effects with lower doses (200-400mg for 2 days monthly). Daily low-dose (100-200mg enhanced) provides sustained neuroprotection, while intermittent higher dosing targets senescent cells.

  • Fisetin provides powerful neuroprotection through antioxidant and anti-inflammatory mechanisms in brain tissue
  • Fisetin promotes neurotrophic factors supporting neuron survival, growth, and synaptic plasticity
  • Fisetin protects against Alzheimer's disease by reducing amyloid and tau accumulation and improving cognition in studies
  • Fisetin extends therapy window for stroke treatment with tissue plasminogen activator, reducing brain damage
  • Formulated fisetin achieves 5-fold better bioavailability - 200mg formulated equals 1000mg standard fisetin
  • Fisetin acts as senolytic, selectively eliminating senescent cells that drive aging and inflammation
  • Fisetin protects mitochondrial function in neurons, supporting cellular energy and brain health
  • Fisetin shows potential for treating multiple neurological disorders through diverse neuroprotective pathways
  1. For daily neuroprotection: Take 100-200mg enhanced bioavailability fisetin daily with meals
  2. For senolytic protocol: Take 200-400mg enhanced fisetin (or 1000mg standard) for 2 consecutive days monthly
  3. Choose enhanced formulations: Look for formulated fisetin with improved bioavailability for 5-fold better absorption
  4. Timing: Take with fatty meal to enhance absorption of this fat-soluble flavonoid
  5. Combination approach: Can combine daily low-dose for neuroprotection with monthly senolytic pulse
  6. With quercetin: Some senolytic protocols combine fisetin with quercetin for complementary effects
  7. Consistency: For neuroprotection, daily use provides sustained brain support and antioxidant benefits
  8. Monitoring: Track cognitive function, energy, and overall well-being; senolytic benefits may take 2-3 months
  • Individuals concerned about brain aging and cognitive decline wanting neuroprotective support
  • People with family history of Alzheimer's or dementia seeking preventive interventions
  • Those experiencing age-related cognitive changes including memory or processing speed decline
  • Individuals interested in senolytic therapy to clear senescent cells and slow aging processes
  • People seeking comprehensive neuroprotection with flavonoid showing multiple brain benefits
  • Those wanting enhanced bioavailability supplements for maximum effectiveness with lower doses
  • Individuals with inflammatory conditions affecting brain or overall health
  • People committed to evidence-based anti-aging strategies including cellular senescence targeting
  • People on blood thinners - fisetin may have antiplatelet effects; consult healthcare provider
  • Those scheduled for surgery within 2 weeks - discontinue fisetin due to potential bleeding effects
  • Individuals on chemotherapy - fisetin may interact with certain cancer treatments; discuss with oncologist
  • Pregnant or breastfeeding women - insufficient safety data for supplementation during these periods
  • People with bleeding disorders - fisetin's antiplatelet properties may increase bleeding risk
  • Those on certain medications - potential interactions with drugs metabolized by specific enzymes

Results: Research demonstrates fisetin prevents and treats neurological disorders through neuroprotective mechanisms. Fisetin shows promise for Alzheimer's disease, Parkinson's disease, stroke, and other brain conditions through antioxidant, anti-inflammatory, and neurotrophic activities.

Citation: Maher P. Brain Plast. 2021;6(2):155-166

Results: Review shows fisetin has multifarious targets for treating neurological and psychiatric disorders. Evidence supports fisetin's potential in neurodegenerative diseases through diverse mechanisms including oxidative stress reduction and neuroinflammation modulation.

Citation: Ravula AR, et al. [Fisetin, potential flavonoid with multifarious targets for neurological disorders]

Results: Pharmacokinetic crossover study demonstrated formulated fisetin 200mg achieved comparable blood levels to standard fisetin 1000mg. Enhanced formulation provides 5-fold improvement in bioavailability, allowing effective dosing with lower amounts.

Citation: Akay. [Crossover pilot pharmacokinetic study of fisetin 1000mg vs formulated fisetin 200mg]

Results: Study shows fisetin prolongs therapy window for tissue plasminogen activator in brain ischemic stroke. Fisetin treatment extends effective treatment time and improves outcomes in stroke models.

Citation: Wang L, et al. [Fisetin Prolongs Therapy Window of Brain Ischemic Stroke Using tPA]